vaccines-gynecologic-oncology-2018-posters

Page 99

Journal of Clinical Immunology and Allergy

ISSN: 2471-304X

E u r o p e a n C o n g r e s s o n

Vaccines & Vaccination

and Gynecologic Oncology

Vaccines & Vaccination and Gynecologic Oncology 2018

O c t o b e r 2 6 - 2 7 , 2 0 1 8

B u d a p e s t , H u n g a r y

ioprocess technology encompasses all of the basic and applied sciences in microbiology, biochemistry and molecular

biology as well as the engineering aspects to fully exploit living systems and bring their products to the market place. To-

day bioprocesses have become widely used in several fields of commercial biotechnology in medicines, veterinary medicines,

food ingredients, agriculture, environmental science and biological chemicals. While our understanding of biotechnological

process has rapidly and remarkably advanced in recent years, it has been in existence since prehistoric times, making it one

of the oldest technology even before the discovery of microbiology. The term of bioconversion that is also known by the name

biotransformation refers to the use of living organisms or its extracted enzymes to carry out chemical reactions that are not

feasible or costly when produced by synthetic chemistry methods. These living organisms convert a substance to a chemically

modified formwith multiple uses and applications. Recent advances in the fields of molecular genetics and nucleic acid chemistry

have resulted in a proliferation of biotechnology products. In medicine, modern biotechnology can be used to manufacture

existing and new biomedicines relatively easily and cheaply. This modern biotechnology find application in biomedicines such

monoclonal antibodies (mAbs), therapeutic proteins, pharmacogenomics, and genetic testing.

The History of Biotechnology in Medicine and It’s

Future Perspectives

Osama O Ibrahim

Bio Innovation Consulting, USA

Journal of Clinical Immunology and Allergy, Volume: 4

DOI: 10.21767/2471-304X-C2-006

Euro Vaccines 2018